- Post-Effective Amendment to Registration Statement (POS AM)
May 01 2009 - 4:32PM
Edgar (US Regulatory)
As
filed with the Securities and Exchange Commission on May 1,
2009
|
Registration
No. 333-154910
|
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
______________________
POST-EFFECTIVE
AMENDMENT NO. 1 TO
FORM
S-8
REGISTRATION
STATEMENT
Under
The
Securities Act of 1933
ARNO
THERAPEUTICS, INC.
(Exact
Name of Registrant as Specified in its Charter)
|
|
Delaware
|
52-2286452
|
(State or Other
Juris-
|
(I.R.S.
Employer
|
diction
of Incorporation
|
Identification
Number)
|
or
Organization)
|
|
4
Campus Drive, 2
nd
Floor
Parsippany,
New Jersey, 07054
(Address
of Principal Executive Office and Zip Code)
Arno
Therapeutics, Inc. 2005 Stock Option Plan
(Full
Title of the Plan)
Brian
Lenz
Chief
Financial Officer
Arno
Therapeutics, Inc.
4 Campus
Drive, 2
nd
Floor
Parsippany,
New Jersey, 07054
(862)
703-7175
(Name,
Address and Telephone Number, Including Area Code, of Agent for
Service)
Copies
to:
Christopher
J. Melsha, Esq.
Fredrikson
& Byron, P.A.
200 South
Sixth Street, Suite 4000
Minneapolis,
MN 55402
Fax:
(612) 492-7077
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting company. See
the definitions of “large accelerated filer,” “accelerated filer” and “smaller
reporting company” in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
Large
accelerated filer
|
o
|
Accelerated
filer
|
o
|
|
Non-accelerated
filer
|
o
|
Smaller
Reporting Company
|
x
|
DEREGISTRATION
OF UNSOLD SECURITIES
On October 31, 2008, Arno Therapeutics,
Inc. (the “Company”) filed a registration statement on Form S-8 (File No.
333-154910) (the “Registration Statement”). The Registration
Statement registered a total of 2,990,655 shares of the Company’s common stock,
par value $0.0001 per share (the “Common Stock”), to be issued pursuant to the
Company’s 2005 Stock Option Plan. The purpose of this Post-Effective
Amendment to the Registration Statement is to withdraw and remove from
registration the unissued and unsold shares of Common Stock previously
registered under the Registration Statement. Consequently, in accordance with an
undertaking made by the Company in the Registration Statement to remove from
registration, by means of a post-effective amendment, any of the securities that
remain unsold at the termination of the offering, the Company hereby removes
from registration the securities of the Company that are registered but unsold
under the Registration Statement.
SIGNATURES
Pursuant to the requirements of the
Securities Act of 1933, the Registrant certifies that it has reasonable grounds
to believe that it meets all of the requirements for filing on Form S-8 and has
duly caused this Post-Effective Amendment No. 1 to its Registration Statement to
be signed on its behalf by the undersigned, thereunto duly authorized, in the
City of Parsippany, State of New Jersey, on May 1, 2009.
|
|
|
|
|
|
|
ARNO
THERAPEUTICS, INC.
|
|
|
|
|
|
|
By:
|
/s/ Brian
Lenz
|
|
|
|
Brian
Lenz
Chief
Financial Officer
|
|
|
|
|
|
|
|
|
|
Pursuant
to the requirements of the Securities Act of 1933, this Post-Effective Amendment
No. 1 to the Registration Statement has been signed below by the following
persons in the capacities and on the dates indicated.
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
*
|
|
Chief
Executive Officer and Director (principal executive
officer)
|
|
May
1, 2009
|
Roger
G. Berlin, M.D.
|
|
|
|
|
|
|
|
/s/ Brian Lenz
|
|
Chief
Financial Officer
|
|
|
Brian
Lenz
|
|
(principal
financial and accounting officer)
|
|
|
|
|
|
*
|
|
Non-Executive
Chairman and Director
|
|
May
1, 2009
|
Arie
S. Belldegrun, M.D.
|
|
|
|
|
|
*
|
|
Director
|
|
May
1, 2009
|
Robert
I. Falk
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
May
1, 2009
|
William
F. Hamilton, Ph.D.
|
|
|
|
|
|
Director
|
|
|
Peter
M. Kash
|
|
|
|
May
__, 2009
|
|
|
|
|
|
*
|
|
Director
|
|
May
1, 2009
|
Joshua
A. Kazam
|
|
|
|
|
|
|
|
*
|
|
Director
and Secretary
|
|
May
1, 2009
|
David
M. Tanen
|
|
|
|
|
|
|
|
|
|
|
|
|
*
/s/ Brian Lenz
|
|
|
|
|
Brian
Lenz
|
|
|
|
|
Attorney-in-fact
|
|
|
Arno Therapeutics (CE) (USOTC:ARNI)
Historical Stock Chart
From May 2024 to Jun 2024
Arno Therapeutics (CE) (USOTC:ARNI)
Historical Stock Chart
From Jun 2023 to Jun 2024